Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Rank in Stocks #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$150.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Poniard Pharmaceuticals, Inc. (PARD)

Category

Price of PARD with the market cap of B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Market Capitalization of Poniard Pharmaceuticals, Inc.(PARD)
Market Cap: $150.00
As of August 2026 Poniard Pharmaceuticals, Inc. has a market cap of $150.00. This makes Poniard Pharmaceuticals, Inc. the world's 42764th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Poniard Pharmaceuticals, Inc. from 1988 to 2026
PARD compared with Top 5 Most Popular stocks
Price of PARD Asset B Mkt. of B Results
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,422 $150.00
$5.426T +3,617,422,497,233.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,949,417 $150.00
$4.424T +2,949,416,916,113.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,765,004 $150.00
$4.148T +2,765,003,561,555.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,436,868 $150.00
$3.655T +2,436,867,543,576.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,927,923 $150.00
$2.892T +1,927,923,257,620.67%